VIGIL NEUROSCIENCE INC(NASDAQ:VIGL) stock News

VIGL Latest News, Press Relases and Analysis

All

Press Releases

15 days ago - By: Benzinga - Mentions: LLY SNY

Eli Lilly's Early Alzheimer's Drug Recommended For Approval By European Drug Regulator's Panel

26 days ago - By: Kahn Swick & Foti, LLC

VIGIL NEUROSCIENCE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Vigil Neuroscience, Inc. - VIGL

2 months ago - By: Zacks Investment Research

Should You Buy Vigil Neuroscience, Inc. (VIGL) After Golden Cross?

a month ago - By: Halper Sadeh LLC - Mentions: CHTR TASK STRM

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CHTR, TASK, VIGL, STRM on Behalf of Shareholders

2 months ago - By: Halper Sadeh LLC - Mentions: CRKN ELEV STR

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CRKN, ELEV, STR, VIGL on Behalf of Shareholders

2 months ago - By: Brodsky & Smith LLC - Mentions: CRKN ELEV STR VNOM ...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Crown Electrokinetics Corp. (OTC - CRKN), Elevation Oncology, Inc. (Nasdaq - ELEV), Sitio Royalties Corp. (NYSE - STR), Vigil Neuroscience, Inc. (Nasdaq - VIGL)

2 months ago - By: Halper Sadeh LLP - Mentions: HURA

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HURA and VIGL on Behalf of Shareholders

2 months ago - By: Brodsky & Smith LLC - Mentions: CRKN ELEV STR VNOM ...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Crown Electrokinetics Corp. (OTC - CRKN), Elevation Oncology, Inc. (Nasdaq - ELEV), Sitio Royalties Corp. (NYSE - STR), Vigil Neuroscience, Inc. (Nasdaq - VIGL)

2 months ago - By: Brodsky & Smith LLC - Mentions: FLS STRM STR GTLS ...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Flowserve Corporation (NYSE – FLS), Streamline Health Solutions, Inc. (Nasdaq – STRM), Sitio Royalties Corp. (NYSE – STR), Vigil Neuroscience, Inc. (Nasdaq – VIGL)

2 months ago - By: Halper Sadeh LLC - Mentions: STR BPMC STRM

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VIGL, STR, BPMC, STRM on Behalf of Shareholders

2 months ago - By: Kaskela Law LLC

VIGIL SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation into Fairness of Vigil Neuroscience, Inc. (NASDAQ: VIGL) Proposed Shareholder Buyout and Encourages Investors to Contact the Firm

2 months ago - By: Vigil Neuroscience, Inc.

Vigil Neuroscience Provides Update on Iluzanebart Phase 2 IGNITE Trial in ALSP

3 months ago - By: Halper Sadeh LLC - Mentions: SGMA STRR

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SGMA, VIGL, STRR on Behalf of Shareholders

3 months ago - By: Zacks Investment Research

Wall Street Analysts Believe Vigil Neuroscience (VIGL) Could Rally 86.68%: Here's is How to Trade

3 months ago - By: Benzinga - Mentions: SPY ADSK INTU AAP ...

US Stocks Likely To Open On A Mixed Note: 'Nothing Good Happens Above A 5% Yield,' Says Expert

3 months ago - By: Yahoo Finance - Mentions: SNY CI HSON STRR ...

Vigil Neuroscience to be acquired by Sanofi for $8.00 per share

3 months ago - By: Kahn Swick & Foti, LLC

VIGIL NEUROSCIENCE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Vigil Neuroscience, Inc. - VIGL

3 months ago - By: Yahoo Finance - Mentions: SNY RUN SEDG AMGN ...

Vigil Neuroscience Stock Triples as Drugmaker Agrees to Acquisition by Sanofi

3 months ago - By: Yahoo Finance - Mentions: LLY AMGN VKTX SNY ...

Better Weight Loss Stock: Amgen or Viking Therapeutics?

3 months ago - By: Zacks Investment Research - Mentions: SNY BIIB LLY

Sanofi to Join Alzheimer's Space With Vigil Neuroscience Buyout

3 months ago - By: Investor's Business Daily - Mentions: SNY AMGN

Sanofi Inks A $470 Million Alzheimer's Deal, Sending This Dollar Stock Flying

3 months ago - By: Ademi & Fruchter LLP

VIGIL NEUROSCIENCE INC (VIGL) Stock News

VIGL Latest News, Press Relases and Analysis

Eli Lilly's Early Alzheimer's Drug Recommended For Approval By European Drug Regulator's Panel

VIGIL NEUROSCIENCE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Vigil Neuroscience, Inc. - VIGL

Should You Buy Vigil Neuroscience, Inc. (VIGL) After Golden Cross?

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CHTR, TASK, VIGL, STRM on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CRKN, ELEV, STR, VIGL on Behalf of Shareholders

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Crown Electrokinetics Corp. (OTC - CRKN), Elevation Oncology, Inc. (Nasdaq - ELEV), Sitio Royalties Corp. (NYSE - STR), Vigil Neuroscience, Inc. (Nasdaq - VIGL)

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HURA and VIGL on Behalf of Shareholders

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Crown Electrokinetics Corp. (OTC - CRKN), Elevation Oncology, Inc. (Nasdaq - ELEV), Sitio Royalties Corp. (NYSE - STR), Vigil Neuroscience, Inc. (Nasdaq - VIGL)

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Flowserve Corporation (NYSE – FLS), Streamline Health Solutions, Inc. (Nasdaq – STRM), Sitio Royalties Corp. (NYSE – STR), Vigil Neuroscience, Inc. (Nasdaq – VIGL)

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VIGL, STR, BPMC, STRM on Behalf of Shareholders

VIGIL SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation into Fairness of Vigil Neuroscience, Inc. (NASDAQ: VIGL) Proposed Shareholder Buyout and Encourages Investors to Contact the Firm

Vigil Neuroscience Provides Update on Iluzanebart Phase 2 IGNITE Trial in ALSP

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SGMA, VIGL, STRR on Behalf of Shareholders

Wall Street Analysts Believe Vigil Neuroscience (VIGL) Could Rally 86.68%: Here's is How to Trade

US Stocks Likely To Open On A Mixed Note: 'Nothing Good Happens Above A 5% Yield,' Says Expert

Vigil Neuroscience to be acquired by Sanofi for $8.00 per share

VIGIL NEUROSCIENCE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Vigil Neuroscience, Inc. - VIGL

Vigil Neuroscience Stock Triples as Drugmaker Agrees to Acquisition by Sanofi

Better Weight Loss Stock: Amgen or Viking Therapeutics?

Sanofi to Join Alzheimer's Space With Vigil Neuroscience Buyout

Sanofi Inks A $470 Million Alzheimer's Deal, Sending This Dollar Stock Flying

Shareholder Alert: The Ademi Firm Investigates Whether Vigil Neuroscience Inc. Is Obtaining a Fair Price for Its Public Shareholders